newsfilter
← Latest News
GlobeNewswire·

Vera Therapeutics Provides Business Update and Reports Third Quarter 2026 Financial Results

TRUTAKNA® (atacicept-vymj) U.S. launch building early momentum following July 7 accelerated approval by the U.S. Food and Drug Administration (FDA) with approximately 700 Patient Start Forms (PSFs) to date and $10.3